Iranian
Biomedical Journal
Volume 29, Issue 3 (5-2025)
IBJ 2025, 29(3): 139-149 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shans N, Esmaeili M, Abraheh K, Asadi Hanjani N, Farrokhi M, Sardarpour N, et al . Development of Experimental Platforms to Assess Helicobacter pylori HopQ Interaction with Host CEACAM Molecules. IBJ 2025; 29 (3) :139-149
URL: http://ibj.pasteur.ac.ir/article-1-5029-en.html
URL: http://ibj.pasteur.ac.ir/article-1-5029-en.html
Nazanin Shans 
, Maryam Esmaeili , Kimia Abraheh , Niloofar Asadi Hanjani , Maedeh Farrokhi , Negar Sardarpour , Yeganeh Talebkhan , Fatemeh Kazemi-Lomedasht , Esmat Mirabzadeh , Marjan Mohammadi *
, Maryam Esmaeili , Kimia Abraheh , Niloofar Asadi Hanjani , Maedeh Farrokhi , Negar Sardarpour , Yeganeh Talebkhan , Fatemeh Kazemi-Lomedasht , Esmat Mirabzadeh , Marjan Mohammadi *
Abstract:
Background: Helicobacter pylori is an extracellular bacterium responsible for various gastrointestinal diseases, such as peptic ulcers and gastric cancer. It uses multiple mechanisms to colonize the harsh, acidic environment of the stomach and establish its pathogenic processes, mostly through CagA translocation. While cell surface integrin molecules were previously believed to be the main mediators anchoring H. pylori and facilitating this process, recent studies highlight the critical role of the interaction between the bacterial adhesin HopQ and host CEACAMs in CagA translocation and subsequent pathogenic signaling.
Methods: Recombinant proteins, including HopQ, HopQ-GFP, HopQ-HRP, and C1ND, were produced via gene cloning, expression, and purification techniques. Ligand-receptor interactions were evaluated using FACS analysis along with antigen- and cell-based ELISA assays.
Results: In this study, we have developed antigen and cell-based platforms using recombinant fusion proteins (HopQ-GFP and HopQ-HRP) that effectively interact with recombinant C1ND, as well as various CEACAM molecules expressed on gastric cell lines (MKN45 and AGS).
Conclusion: These assay platforms enable detailed investigation of the HopQ-CEACAM interaction and supports high-throughput screening of inhibitors, facilitating the identification of potential drugs or vaccine candidates targeting H. pylori infection.
Methods: Recombinant proteins, including HopQ, HopQ-GFP, HopQ-HRP, and C1ND, were produced via gene cloning, expression, and purification techniques. Ligand-receptor interactions were evaluated using FACS analysis along with antigen- and cell-based ELISA assays.
Results: In this study, we have developed antigen and cell-based platforms using recombinant fusion proteins (HopQ-GFP and HopQ-HRP) that effectively interact with recombinant C1ND, as well as various CEACAM molecules expressed on gastric cell lines (MKN45 and AGS).
Conclusion: These assay platforms enable detailed investigation of the HopQ-CEACAM interaction and supports high-throughput screening of inhibitors, facilitating the identification of potential drugs or vaccine candidates targeting H. pylori infection.
Type of Study: Full Length/Original Article |
Subject:
Medical Biotechnology
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |